Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(14 sites)

United States

St Luke's Hospital, Kansas City, Kansas

University of Pennsylvania, Philadelphia, Pennsylvania

University of Pittsburgh, Pittsburgh, Pennsylvania

Germany

University of Augsburg, Augsburg

Charite Berlin, Berlin